NILO Therapeutics, Inc. — Form D
NILO Therapeutics, Inc. of New York, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-08-02. The offering totals $101.0M, of which $9.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-08-02
- Form: D
- Accession: 0002031964-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $101.0M
- Amount sold: $9.6M
- Remaining: $91.4M
- Investors: 3
- Date of first sale: 2024-07-18
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-520504
Issuer
- Name: NILO Therapeutics, Inc.
- CIK: 0002031964
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 430 E 29th St, Suite 625, New York, NY, 10016
- Phone: 415-865-2050
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Jeff Goater | Director | New York, NY |
| Tim Kutzkey | Director | South San Francisco, CA |
| Jeff Goater | Executive Officer | New York, NY |
| Tim Kutzkey | Executive Officer | South San Francisco, CA |
| Tim Kutzkey | Promoter | South San Francisco, CA |
More